HealthStream (HSTM)

$33.13 +2.03% on the day Market cap $968M 52-week range $19.50 to $33.21 Prices as of Oct 11, 2026

What the price implies

A reverse DCF: instead of guessing a fair value, it asks what growth today's price already assumes. How it works.

Free cash flow growth the price needs
11% a year for 10 years

At a market value of $968M, HealthStream's free cash flow of $31M (fiscal 2025) would need to grow about 11% a year for the stock to be worth today's price. That is close to what the company has delivered over the last 9 years.

Assumes a 9% discount rate and 3% growth after year 10, on free cash flow (operating cash flow minus capital spending) from HealthStream's SEC filings. Change any assumption, or model revenue and margins instead, in the Modeling tab, or try your own numbers in the reverse DCF calculator.

Implied by the price10.8% a year
Free cash flow, last 9 years12.9% a year
Revenue, same period5.2% a year
Price to free cash flow31.1x

Fundamental grade

C

Five factors scored 1 to 9 from HSTM's latest numbers, weighted into one grade. It describes the business, not whether the stock is a buy.

Valuation4
Profitability6
Growth7
Financial health5
Cash efficiency7

Results from SEC filings

Fiscal years, from HealthStream's 10-K filings. Ten years of the full income statement, balance sheet and cash flow.

Fiscal year20212022202320242025
Revenue$257M$267M$279M$292M$304M
Net income$6M$12M$15M$20M$18M
Free cash flow$17M$26M$36M$30M$31M
EPS (diluted)$0.18$0.39$0.50$0.66$0.61
Operating margin3.1%4.7%5.7%7.3%6.7%

Where the revenue comes from

Revenue by segments, fiscal 2022. Every breakdown, year by year.

Healthstream Workforce Solutions$214M80%
Healthstream Provider Solutions$53M20%

Superinvestors who own HSTM

From each investor's latest 13F filing (what a 13F shows). 2 of the investors we track hold it.

InvestorLast quarterValue% of portfolioQuarter
Jean-Marie Eveillard
First Eagle Investment Management
Added $16M0.03%Q2 2026
Cliff Asness
AQR Capital Management
Added $7M0.00%Q2 2026

Insider buying

Open-market purchases by HealthStream's executives and directors in the last 12 months, from SEC Form 4 filings. What insider buying tells you.

No open-market insider purchases of HSTM in the last 12 months. Most insider activity is selling and option exercises, which aren't shown here.

Get an alert at your buy price

Pick the price you'd be interested at. We'll email you when HSTM trades at or below it.

$

New accounts get 7 days of Pro, price alerts included. No card needed.

In the full deep dive

DCF fair value per share
Yearly return (IRR) at today's price
Growth implied by revenue and margins
15+ years of statements and quarters

Questions

What growth does HealthStream's stock price imply?

At a market value of $968M, HealthStream would need its free cash flow to grow about 11% a year for 10 years (discounted at 9%, 3% growth after that) to be worth today's price. Over the last 9 years its free cash flow grew 13% a year.

Are HealthStream insiders buying the stock?

No open-market insider purchases of HSTM in the last 12 months, according to SEC Form 4 filings.

Which superinvestors own HealthStream?

2 of the superinvestors Investingly tracks hold HSTM in their latest 13F, including Jean-Marie Eveillard, Cliff Asness.

Prices and ratios as of Oct 11, 2026; statements from SEC filings. Information only, not investment advice. Superinvestor holdings come from 13F filings, which are filed up to 45 days after each quarter ends.